SCHEMBL19232193

SCHEMBL19232193

CC(C)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CSSCC(C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC1=O

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 1/20 0.56
PCSK9 Q8NBP7 1/20 0.53
SSTR4 P31391 14/20 0.52
SSTR2 P30874 12/20 0.52
SSTR3 P32745 11/20 0.52
SSTR5 P35346 11/20 0.52
SSTR1 P30872 6/20 0.52
PLAU P00749 2/20 0.50
PRKACA P17612 1/20 0.49
PRKACG P22612 1/20 0.49
PRKACB P22694 1/20 0.49
CTSG P08311 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19232199 0.93 CACNA1B (0.65) CACNA1BPCSK9SSTR4SSTR2SSTR3
SCHEMBL25455154 0.85 CACNA1B (0.61) CACNA1BPCSK9SSTR4SSTR2SSTR3
SCHEMBL19232224 0.84 CACNA1B (0.62) CACNA1BSSTR4SSTR2SSTR3SSTR5
SCHEMBL20910241 0.83 CACNA1B (0.60) CACNA1BPLAUCTSG
SCHEMBL29666839 0.78 SSTR4 (0.51) CACNA1BSSTR4SSTR2SSTR3SSTR5
SCHEMBL19232225 0.78 CACNA1B (0.68) CACNA1BSSTR4SSTR2SSTR3SSTR5
SCHEMBL25456827 0.77 CACNA1B (0.53) CACNA1BPCSK9SSTR4SSTR2SSTR3
SCHEMBL25455142 0.76 KEAP1 (0.53) CACNA1BSSTR4SSTR2SSTR3SSTR5
SCHEMBL23322935 0.76 F12 (0.58) PCSK9PLAU
SCHEMBL31479909 0.76 HSP90AB1 (0.45) CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017136581-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATE MEDITOPE BIOSCIENCES, INC. (US) 2017-08-10 WO disclosed